Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve

Charles C Vining; Francisco Izquierdo; Oliver S Eng; Kiran K Turaga

doi:10.1002/jso.25939

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve

J Surg Oncol. 2020 Jul;122(1):85-95. doi: 10.1002/jso.25939. Epub 2020 May 20.

Authors

Charles C Vining¹, Francisco Izquierdo², Oliver S Eng¹, Kiran K Turaga¹

Affiliations

¹ Department of Surgery, University of Chicago, Chicago, Illinois.
² Department of Surgery, Clinica Santa Maria, Santiago, Chile.

PMID: 32436240
DOI: 10.1002/jso.25939

Abstract

Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved safety and favorable oncologic outcomes, including curative potential. CRS/HIPEC has a steep learning curve and requires familiarity with peritonectomy procedures. This review will outline the technical aspects and learning curve of CRS/HIPEC.

Keywords: HIPEC; cytoreductive surgery; learning curve; peritoneal metastasis; surgical education.

Publication types

Review

MeSH terms

Cytoreduction Surgical Procedures / methods*
Humans
Hyperthermia, Induced / methods*
Learning Curve
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*
Peritoneum / surgery